A body rejects an organ because its immune system identifies the new organ as foreign and attacks it in an attempt to protect itself.
The Immune System's Role in Organ Rejection
The human immune system is designed to defend the body against harmful invaders like bacteria, viruses, and other foreign substances. It distinguishes between "self" (the body's own cells) and "non-self" (foreign substances). When a transplanted organ is introduced, the immune system recognizes it as "non-self" because the organ's cells have different surface markers (antigens) than the recipient's own cells. This triggers an immune response aimed at destroying the perceived threat.
Types of Organ Rejection
There are primarily two types of organ rejection:
-
Acute Rejection: This type of rejection typically occurs within the first few weeks or months after transplantation. The immune system actively attacks the transplanted organ, causing inflammation and damage. Symptoms can vary depending on the organ transplanted but often include fever, pain at the transplant site, and organ dysfunction. Acute rejection is often treatable with immunosuppressant medications.
-
Chronic Rejection: This is a slower, more gradual process that can occur over months or years. It involves a complex interaction of immune and non-immune factors that lead to progressive damage and scarring of the transplanted organ. Chronic rejection is often more difficult to treat and can ultimately lead to organ failure.
Immunosuppressant Medications
To prevent organ rejection, transplant recipients must take immunosuppressant medications for the rest of their lives. These drugs suppress the immune system's response to the transplanted organ, preventing it from attacking and destroying it. However, these medications also weaken the immune system's ability to fight off infections and other illnesses, making transplant recipients more vulnerable to these complications.
Factors Influencing Rejection Risk
Several factors can influence the risk of organ rejection:
- Human Leukocyte Antigen (HLA) Matching: HLA markers are proteins found on the surface of cells that help the immune system distinguish between self and non-self. Better HLA matching between the donor and recipient reduces the risk of rejection.
- Immunosuppression Regimen: The type and dosage of immunosuppressant medications used can significantly impact the risk of rejection.
- Recipient's Immune System: The strength and activity of the recipient's immune system can also influence the likelihood of rejection.
- Overall Health: The recipient's overall health and any pre-existing medical conditions can also play a role.
- Previous Transfusions/Pregnancies: Prior exposure to foreign antigens through blood transfusions or pregnancies can sensitize the immune system and increase the risk of rejection.
Managing Organ Rejection
If organ rejection occurs, treatment typically involves adjusting the immunosuppression regimen. This may include increasing the dosage of existing medications or adding new medications to the regimen. In some cases, more aggressive treatments such as antibody therapy or plasmapheresis may be necessary. While rejection can sometimes be reversed, it can also lead to permanent damage and organ failure, requiring re-transplantation.
In summary, organ rejection happens because the body's immune system is designed to protect itself from foreign invaders, and it identifies a transplanted organ as such. Immunosuppressant medications are crucial for preventing rejection, but they also carry risks. Careful matching of donor and recipient characteristics and close monitoring of the transplant recipient are essential for minimizing the risk of rejection and ensuring the long-term success of organ transplantation.
